{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "clinical practice guidelines",
      "depression",
      "inadequate response",
      "systematic review"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "Cette revue syst\u00e9matique a \u00e9valu\u00e9 de fa\u00e7on critique les guides de pratique clinique (GPC) sur le traitement des adultes souffrant de trouble d\u00e9pressif majeur (TDM), de dysthymie, ou de d\u00e9pression mineure ou infraliminaire pour des recommandations suivant une r\u00e9ponse inad\u00e9quate \u00e0 un traitement de premi\u00e8re ligne par inhibiteur sp\u00e9cifique du recaptage de la s\u00e9rotonine (ISRS).",
        "Les recherches dans les GPC (01/2004-11/2014) en anglais ont rep\u00e9r\u00e9 7 bases de donn\u00e9es bibliographiques et des sources de litt\u00e9rature grise \u00e0 l\u2019aide des mots-cl\u00e9s GPC et d\u00e9pression. Deux \u00e9valuateurs ont s\u00e9lectionn\u00e9 un GPC sur la d\u00e9pression ayant une port\u00e9e nationale. Les extractions de donn\u00e9es comprenaient des d\u00e9finitions de r\u00e9ponse ad\u00e9quate et recommandaient des options de traitement. Deux \u00e9valuateurs ont estim\u00e9 la qualit\u00e9 \u00e0 l\u2019aide de l\u2019instrument Grille d\u2019\u00e9valuation de la qualit\u00e9 des recommandations pour la pratique clinique (AGREE II).",
        "Sur 46 908 citations, 3 167 ont \u00e9t\u00e9 s\u00e9lectionn\u00e9es selon le texte int\u00e9gral, 21 GPC uniques applicables aux adultes des soins de premi\u00e8re ligne et des contextes ambulatoires ont \u00e9t\u00e9 examin\u00e9s. Cinq GPC abordent les patients souffrant de dysthymie ou de d\u00e9pression mineure ou infraliminaire. Aucun n\u2019offre de recommandations pour ceux qui ne r\u00e9pondent pas au traitement de premi\u00e8re ligne par ISRS. Pour les adultes souffrant de TDM, la plupart des GPC ne d\u00e9finissent pas une \u00ab r\u00e9ponse inad\u00e9quate \u00bb et n\u2019offrent pas de suggestions pr\u00e9cises sur la fa\u00e7on de choisir des m\u00e9dicaments de rechange quand on passe \u00e0 un autre antid\u00e9presseur. Il y a une variabilit\u00e9 entre les GPC qui recommandent des strat\u00e9gies de combinaison. Les normes d\u2019AGREE II pour la participation des intervenants \u00e0 l\u2019\u00e9laboration des GPC, l\u2019ind\u00e9pendance \u00e9ditoriale et la rigueur du d\u00e9veloppement sont des domaines dans lesquels les guides sur la d\u00e9pression sont souvent moins fermes.",
        "Environ la moiti\u00e9 des patients souffrant de d\u00e9pression n\u00e9cessitent un traitement de deuxi\u00e8me ligne pour obtenir une r\u00e9mission. La coh\u00e9rence et la clart\u00e9 des guides pour le traitement de deuxi\u00e8me ligne de la d\u00e9pression sont donc importantes pour les cliniciens, mais elles sont absentes dans la plupart des guides actuels. Ceci peut refl\u00e9ter une raret\u00e9 d\u2019\u00e9tudes primaires sur lesquelles fonder des conclusions."
      ]
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "27554483",
  "DateCompleted": {
    "Year": "2017",
    "Month": "12",
    "Day": "08"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "12"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2016",
        "Month": "09",
        "Day": "24"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1177/0706743716664885"
    ],
    "Journal": {
      "ISSN": "1497-0015",
      "JournalIssue": {
        "Volume": "62",
        "Issue": "1",
        "PubDate": {
          "Year": "2017",
          "Month": "Jan"
        }
      },
      "Title": "Canadian journal of psychiatry. Revue canadienne de psychiatrie",
      "ISOAbbreviation": "Can J Psychiatry"
    },
    "ArticleTitle": "Systematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults.",
    "Pagination": {
      "StartPage": "11",
      "EndPage": "23",
      "MedlinePgn": "11-23"
    },
    "Abstract": {
      "AbstractText": [
        "This systematic review critically evaluated clinical practice guidelines (CPGs) for treating adults with major depressive disorder, dysthymia, or subthreshold or minor depression for recommendations following inadequate response to first-line treatment with selective serotonin reuptake inhibitors (SSRIs).",
        "Searches for CPGs (January 2004 to November 2014) in English included 7 bibliographic databases and grey literature sources using CPG and depression as the keywords. Two raters selected CPGs on depression with a national scope. Data extraction included definitions of adequate response and recommended treatment options. Two raters assessed quality using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument.",
        "From 46,908 citations, 3167 were screened at full text. From these 21 CPG were applicable to adults in primary care and outpatient settings. Five CPGs consider patients with dysthymia or subthreshold or minor depression. None provides recommendations for those who do not respond to first-line SSRI treatment. For adults with MDD, most CPGs do not define an \"inadequate response\" or provide specific suggestions regarding how to choose alternative medications when switching to an alternative antidepressant. There is variability between CPGs in recommending combination strategies. AGREE II ratings for stakeholder involvement in CPG development, editorial independence, and rigor of development are domains in which depression guidelines are often less robust.",
        "About half of patients with depression require second-line treatment to achieve remission. Consistency and clarity in guidelines for second-line treatment of depression are therefore important for clinicians but lacking in most current guidelines. This may reflect a paucity of primary studies upon which to base conclusions."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "1 Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta."
          }
        ],
        "LastName": "MacQueen",
        "ForeName": "Glenda",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "2 Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario."
          }
        ],
        "LastName": "Santaguida",
        "ForeName": "Pasqualina",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "2 Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario."
          }
        ],
        "LastName": "Keshavarz",
        "ForeName": "Homa",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "3 Department of Psychiatry, McGill University, Montreal, Quebec."
          }
        ],
        "LastName": "Jaworska",
        "ForeName": "Natalia",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "2 Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario."
          }
        ],
        "LastName": "Levine",
        "ForeName": "Mitchell",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "2 Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario."
          }
        ],
        "LastName": "Beyene",
        "ForeName": "Joseph",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "2 Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario."
          }
        ],
        "LastName": "Raina",
        "ForeName": "Parminder",
        "Initials": "P"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review",
      "Systematic Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Can J Psychiatry",
    "NlmUniqueID": "7904187",
    "ISSNLinking": "0706-7437"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antidepressive Agents"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Depressive Disorder, Major"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Depressive Disorder, Treatment-Resistant"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Dysthymic Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "standards"
      ],
      "DescriptorName": "Practice Guidelines as Topic"
    }
  ],
  "CoiStatement": "The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."
}